AgingResearch.NewsJoin free

Invirsa

CompanyUnited States

Invirsa develops one asset, in phase 2 (INV-102 in center-involved diabetic macular edema). Mostly small molecule; based in the United States.

1
Asset
Furthest stage
Phase 2
1
Trial
0
Signals

Pipeline

1

  • INV-102

    Activates innate mucosal immune repair pathways and promotes corneal/retinal epithelial healing.

    Phase 2, Small molecule, center-involved diabetic macular edema, center-involved diabetic macular edema associated with non-proliferative diabetic retinopathy

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials1
  • Similar companies6

Intelligence